Feature|Articles|December 10, 2023
- Pharmaceutical Executive: December 2023
- Volume 43
- Issue 12
Pharmaceutical Executive: December 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Finding that Sparkalmost 2 years ago
Remote Reliance: The Rise of Oncology Home Carealmost 2 years ago
It’s Always Important to Remember: Leaders Make Mistakesalmost 2 years ago
Will Calendar Change Bring an End to Run of Volatility in Biotech?almost 2 years ago
FDA, Industry Face Challenges in the Year Aheadalmost 2 years ago
Navigating the Future: Key Market Access Trends to Watch in ’24almost 2 years ago
Reflecting on 2023Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
